TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the TransMedics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Stay updated with breaking news from Jacob Schroder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good afternoon and welcome to the TransMedics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
The new-generation device was implanted into a 39-year-old man by a surgical team led by Dr. Jacob Schroder and Dr. Carmelo Milano on Wednesday. A process that seems pretty routine, but it was a difficult decision considering no procedure like this has been done before.
Most transplanted hearts are from donors who are brain dead, but new research shows a different approach can be just as successful and boost the number of available organs.
A relatively new kind of heart transplant allows for the use of hearts donated after circulatory death.
Last year, 4,111 heart transplants were performed in the U.S., a record number but not nearly enough to meet the need.